Hoth Therapeutics (HOTH) News Today $1.06 -0.02 (-1.85%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.06 -0.01 (-0.47%) As of 02/21/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period D. Boral Capital Reaffirms Buy Rating for Hoth Therapeutics (NASDAQ:HOTH)February 12, 2025 | americanbankingnews.comHoth Therapeutics announces collaboration with OnTargetx R&DFebruary 10, 2025 | markets.businessinsider.comHoth Therapeutics Partners with OnTargetx R&D to Advance Research for Cancer fighting HT-KIT Cancer TherapeuticFebruary 10, 2025 | prnewswire.comHoth Therapeutics expands at-the-market offering by $5 millionFebruary 8, 2025 | msn.comHoth Therapeutics regains compliance with Nasdaq listing rulesJanuary 25, 2025 | markets.businessinsider.comHoth Therapeutics Restores Compliance With Nasdaq Listing RequirementsJanuary 24, 2025 | markets.businessinsider.comHoth Therapeutics Regains Compliance with Nasdaq Listing RequirementsJanuary 24, 2025 | prnewswire.comHoth Therapeutics expands cancer drug patent portfolioJanuary 21, 2025 | msn.comHoth Therapeutics Expands IP Portfolio With New Patent ApplicationsJanuary 21, 2025 | markets.businessinsider.comHoth Therapeutics Expands Intellectual Property Portfolio with Acquisition of New Patent ApplicationsJanuary 21, 2025 | prnewswire.comHoth Therapeutics to Attend Sequire Investor Summit January 21-23, 2025January 17, 2025 | prnewswire.comHoth Therapeutics: Strong balance sheet includes over $10M cash, no debtJanuary 10, 2025 | markets.businessinsider.comHoth Therapeutics affirms no plans for public, private offering at this timeJanuary 10, 2025 | markets.businessinsider.comHoth Therapeutics responds to market rumors, says no plans for offeringJanuary 10, 2025 | markets.businessinsider.comHoth Therapeutics Shares Recover; Company Has No Plans for OfferingJanuary 9, 2025 | marketwatch.comHoth Therapeutics Responds to Market Rumors and Shareholder InquiriesJanuary 8, 2025 | prnewswire.comShares Of This Micro Cap More Than Doubled TodayJanuary 8, 2025 | msn.comHoth Therapeutics reports ‘encouraging’ results from Phase 2a trial of HT-001January 8, 2025 | markets.businessinsider.comD. Boral says Hoth findings highlight HT-001 potential to ‘revolutionize’ careJanuary 8, 2025 | markets.businessinsider.comHoth Therapeutics’ Stock Triples On Promising Cancer Trial Data for Skin Toxicity Therapy: Retail’s ExcitedJanuary 8, 2025 | msn.comHoth Therapeutics Shares Hit 52-Week High on Positive Data for Cancer TreatmentJanuary 7, 2025 | marketwatch.comHoth Therapeutics Achieves Breakthrough in Phase 2a Trial: HT-001 Delivers 100% Success in Combating Cancer Treatment Skin ToxicitiesJanuary 7, 2025 | prnewswire.comHoth Therapeutics partners with Dept. of Veterans Affairs on obesity treatmentDecember 27, 2024 | markets.businessinsider.comWhy Hoth Therapeutics Is Rising In Pre-market?December 26, 2024 | markets.businessinsider.comHoth licenses patents to develop anti-obesity treatmentsDecember 26, 2024 | msn.comHoth Therapeutics Enters Partnership with the Department of Veterans Affairs to Develop Obesity TreatmentDecember 26, 2024 | prnewswire.comBitcoin buyer MicroStrategy ends flat after getting Nasdaq 100 nodDecember 17, 2024 | msn.comCanadian Wellness Company Approves $1 Million Bitcoin Treasury InvestmentNovember 27, 2024 | msn.comMicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000November 23, 2024 | msn.comHoth Up on Bitcoin BuyNovember 20, 2024 | baystreet.caHoth Therapeutics Board of Directors Approves Bitcoin as Treasury Reserve AssetNovember 20, 2024 | prnewswire.comHoth Therapeutics shares hold buy as study shows cancer treatment promiseNovember 7, 2024 | investing.comHoth Therapeutics Up 34% on Favorable Early Data for Preclinical Study of Cancer DrugOctober 30, 2024 | marketwatch.comHoth Therapeutics: Treatment ‘successfully’ stabilized tumor growth in studyOctober 30, 2024 | markets.businessinsider.comHoth Therapeutics Announces Update on Cancer Therapeutic HT-KIT Results Suggesting the Treatment Effectively Inhibited Tumor Growth in Preclinical Treatment StudyOctober 29, 2024 | prnewswire.comHoth Therapeutics, Inc.October 17, 2024 | cnn.comHoth Shares Rise After Alzheimer's Treatment Gets PatentOctober 15, 2024 | marketwatch.comHoth Therapeutics Awarded Key US Patent for Groundbreaking Alzheimer's Treatment and Prepares for Clinical Trials of HT-ALZ with Formulation Now UnderwayOctober 15, 2024 | prnewswire.comHoth Therapeutics Reports Encouraging Pre-clinical Data For Its Alzheimer's Drug; Stock UpSeptember 17, 2024 | markets.businessinsider.comHoth Therapeutics Shares Rally on Positive Alzheimer's Pre-clinical Study DataSeptember 17, 2024 | marketwatch.comHoth Therapeutics Announces Promising Preclinical Results for Alzheimer's Drug HT-ALZSeptember 17, 2024 | prnewswire.comHoth Therapeutics (NASDAQ:HOTH) Stock Quotes, Forecast and News SummarySeptember 6, 2024 | benzinga.comEvolve Canadian Utilities Enhanced Yield Index Fund (UTES.TO)September 5, 2024 | finance.yahoo.comHoth Stock Soars On Announcement Of Positive Data For HT-001 In EGFRI-Associated Skin ToxicitiesSeptember 5, 2024 | markets.businessinsider.comHoth Therapeutics Reports Favorable Results for First-of-Its-Kind HT-001 Treatment of a PatientSeptember 5, 2024 | marketwatch.comHoth Therapeutics Announces Expansion of Clinical Sites for HT-001 Phase 2a TrialSeptember 5, 2024 | prnewswire.comHoth Therapeutics Announces Positive Data from First-of-its-Kind Human Patient Treatment of EGFRI-Associated Skin Toxicities with HT-001September 5, 2024 | prnewswire.comPhanes acquires second FDA orphan designation for bispecific antibodyAugust 20, 2024 | msn.comHoth Therapeutics, Inc. (NASDAQ:HOTH) CEO Acquires 25,000 SharesAugust 20, 2024 | insidertrades.comHoth Therapeutics, Inc. (HOTH) latest stock news & headlines – Yahoo FinanceAugust 18, 2024 | nz.finance.yahoo.com Get Hoth Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HOTH and its competitors with MarketBeat's FREE daily newsletter. Email Address HOTH Media Mentions By Week HOTH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HOTH News Sentiment▼0.000.60▲Average Medical News Sentiment HOTH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HOTH Articles This Week▼01▲HOTH Articles Average Week Get Hoth Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HOTH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ProMIS Neurosciences News CEL-SCI News Marinus Pharmaceuticals News Coeptis Therapeutics News Akari Therapeutics News NKGen Biotech News Pulmatrix News Chemomab Therapeutics News Lexaria Bioscience News Cyclo Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HOTH) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hoth Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hoth Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HOTH Stock Alerts